NFKB1 and cancer: NF-κB is activated primarily on T lymphocytes in response to T-cell receptor signaling but also in response to proinflammatory stimuli, where it protects tumor cells from death in many cancers, thereby influencing tumor development and cancer treatment resistance [46,47].